http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36367834

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 1176
issn 1539-6509
issueIdentifier 179
pageRange 1167-1176
publicationName Discovery Medicine
startingPage 1167
bibliographicCitation Yang J, Jiang X, Chen Y, Teng L. EIF5A2 Promotes Doxorubicin Resistance in Bladder Cancer Cells through the TGF-β Signaling Pathway. Discov Med. 2023 Dec;35(179):1167–76. doi: 10.24976/discov.med.202335179.113. PMID: 38058082.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ebb891ab98c034aab4a0782aadf590b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b67c6fe084f08ec585f4cfa3207916e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fd1b93eab16445c0e38577d22da6400
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1d3e946c42697d09e5612aa530086d7
date 202312
identifier https://doi.org/10.24976/discov.med.202335179.113
https://pubmed.ncbi.nlm.nih.gov/38058082
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32839
https://portal.issn.org/resource/ISSN/1539-6509
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title EIF5A2 Promotes Doxorubicin Resistance in Bladder Cancer Cells through the TGF-β Signaling Pathway
discusses http://id.nlm.nih.gov/mesh/M0585628
http://id.nlm.nih.gov/mesh/M0024757
http://id.nlm.nih.gov/mesh/M0006784
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001749Q000188
http://id.nlm.nih.gov/mesh/D001749Q000235
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D004317Q000627
http://id.nlm.nih.gov/mesh/D015398
http://id.nlm.nih.gov/mesh/D049109
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D004317Q000494
http://id.nlm.nih.gov/mesh/D016212

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56648

Total number of triples: 34.